Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 8INDUSTRY 5NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 58Lymphoid 41Head & Neck 36Sarcoma 35Genitourinary 34Thoracic 32Gastrointestinal 30Other hematologic neoplasm 25Gynecologic 21Breast 21Classical hematology 5Myeloid 3Dermatologic 3Tumor-Agnostic 2Plasma cell 2Other solid neoplasm 1Other 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Fibroblast Growth Factor 7 2isatuximab 1Taxes 1Tadalafil 1Sildenafil Citrate 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Psychiatric Rehabilitation 1Paclitaxel 1Neck Dissection 1Cisplatin 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Radiotherapy × Other × Clear all
NCT00360971 2017-12-26

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Terminated
21 enrolled 10 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Pain, Radiation Injuries, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡